Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo

Human Gene Therapy

Volumn 16, Issue 12, 2005, Pages 1377-1388

  Cascante, Anna ^a   Huch, Meritxell ^a   Rodríguez, Laura Garcia ^a   González, Juan Ramón ^a   Costantini, Lauren ^b   Fillat, Cristina ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b Titan Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; GANCICLOVIR; GELATIN; TAT8 THYMIDINE KINASE FUSION PROTEIN; THYMIDINE KINASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SYNTHESIS; ELECTROGENE; EMBRYO; GENE EXPRESSION; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS TUMOR; PROTEIN DOMAIN; SUICIDE GENE THERAPY; TUMOR REGRESSION; TUMOR VOLUME; WILD TYPE;

3T3 CELLS; ANIMALS; GANCICLOVIR; GENE PRODUCTS, TAT; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMPLEXVIRUS;

EID: 29244451451     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.1377     Document Type: Article

References (39)

1. BAKAY, R.A., KAISER, C.D., STOVER, N.P., SUBRAMANIAN, T., CORNFELDT, M.L., SCHWEIKERT, A.W., ALLEN, R.C., and WATTS, R. (2004). Implantation of spheramine in advanced Parkinson's disease (PD). Front. Biosci. 9, 592-602.
2. BEERENS, A.M., AL HADITHY, A.F., ROTS, M.G., and HAISMA, H.J. (2003). Protein transduction domains and their utility in gene therapy. Curr. Gene Ther. 3, 486-494.
3. BENUSSI, L., ALBERICI, A., MAYHAUS, M., LANGER, U., GHIDONI, R., MAZZOLI, F., NICOSIA, F., BARBIERO, L., FRISONI, G., ZANETTI, O., GASPARINI, L., NITSCH, R.M., and BINETTI, G. (2001). Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: A release enhanced by apoptosis. Exp. Cell Res. 269, 256-265.
4. CARRIO, M., ROMAGOSA, A., MERCADE, E., MAZO, A., NADAL, M., GOMEZ-FOIX, A.M., and FILLAT, C. (1999). Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene. Gene Ther. 6, 547-553.
5. CARRIO, M., MAZO, A., LOPEZ-IGLESIAS, C., ESTIVILL, X., and FILLAT, C. (2001). Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: Implications for gene therapy. Int. J. Cancer 94, 81-88.
6. CARRIO, M., VISA, J., CASCANTE, A., ESTIVILL, X., and FILLAT, C. (2002). Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model: Combination with the HSVtk/GCV system. J. Gene Med. 4, 141-149.
7. CASHMAN, S.M., MORRIS, D.J., and KUMAR-SINGH, R. (2003). Evidence of protein transduction but not intercellular transport by proteins fused to HIV Tat in retinal cell culture and in vivo. Mol. Ther. 8, 130-142.
8. DIMAIO, J.M., CLARY, B.M., VIA, D.F., COVENEY, E., PAPPAS, T.N., and LYERLY, H.K. (1994). Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 116, 205-213.
9. ELLIOTT, G., and O'HARE, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
10. FAWELL, S., SEERY, J., DAIKH, Y., MOORE, C., CHEN, L.L., PEPINSKY, B., and BARSOUM, J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 664-668.
11. FERRARI, A., PELLEGRINI, V., ARCANGELI, C., FITTIPALDI, A., GIACCA, M., and BELTRAM, F. (2003). Caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time. Mol. Ther. 8, 284-294.
12. GOLDMAN, M.H., JAMES, D.C., RENDALL, M., ISON, A.P., HOARE, M., and BULL, A.T. (1998). Monitoring recombinant human interferon-γ N-glycosylation during perfused fluidized-bed and stirred-tank batch culture of CHO cells. Biotechnol. Bioeng. 60, 596-607.
13. GOTO, T., NISHI, T., TAMURA, T., DEV, S.B., TAKESHIMA, H., KOCHI, M., YOSHIZATO, K., KURATSU, J., SAKATA, T., HOFMANN, G.A., and USHIO, Y. (2000). Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 97, 354-359.
14. HO, A., SCHWARZE, S.R., MERMELSTEIN, S.J., WAKSMAN, G., and DOWDY, S.F. (2001). Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477.
15. IVANOV, M.A., LAMRIHI, B., SZYF, M., SCHERMAN, D., and BIGEY, P. (2003). Enhanced antitumor activity of a combination of MBD2-antisense electrotransfer gene therapy and bleomycin electrochemotherapy. J. Gene Med. 5, 893-899.
16. JOLIOT, A., PERNELLE, C., DEAGOSTINI-BAZIN, H., and PROCHIANTZ, A. (1991). Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88, 1864-1868.
17. KISTNER, O., BARRETT, P.N., MUNDT, W., REITER, M., SCHOBER-BENDIXEN, S., and DORNER, F. (1998). Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16, 960-968.
18. LEIFERT, J.A., and WHITTON, J.L. (2003). "Translocatory proteins" and "protein transduction domains": A critical analysis of their biological effects and the underlying mechanisms. Mol. Ther. 8, 13-20.
19. LEIFERT, J.A., HARKINS, S., and WHITTON, J.L. (2002). Full-length proteins attached to the HIV Tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther. 9, 1422-1428.
20. LUNDBERG, M., WIKSTROM, S., and JOHANSSON, M. (2003). Cell surface adherence and endocytosis of protein transduction domains. Mol. Ther. 8, 143-150.
21. MERILAINEN, O., HAKKARAINEN, T., WAHLFORS, T., PELLINEN, R., and WAHLFORS, J. (2005). HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: A study with TAT-TK-GFP triple fusion construct. Int. J. Oncol. 27, 203-208.
22. MESNIL, M., PICCOLI, C., TIRABY, G., WILLECKE, K., and YAMASAKI, H. (1996). Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. U.S.A. 93, 1831-1835.
23. MESNIL, M., PICCOLI, C., and YAMASAKI, H. (1997). A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res. 57, 2929-2932.
24. MIR, L.M., BELEHRADEK, M., DOMENGE, C., ORLOWSKI, S., PODDEVIN, B., BELEHRADEK, J., Jr., SCHWAAB, G., LUBOINSKI, B., and PAOLETTI, C. (1991). [Electrochemotherapy, a new antitumor treatment: First clinical trial]. C. R. Acad. Sci. III 313, 613-618.
25. MIR, L.M., BUREAU, M.F., GEHL, J., RANGARA, R., ROUY, D., CAILLAUD, J.M., DELAERE, P., BRANELLEC, D., SCHWARTZ, B., and SCHERMAN, D. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. U.S.A. 96, 4262-4267.
26. PINHEIRO, J.C., and BATES, D.M. (2000). Mixed-Effects Models in S and S-PLUS. (Springer-Verlag, New York).
27. REYES, G., VILLANUEVA, A., GARCIA, C., SANCHO, F.J., PIULATS, J., LLUIS, F., and CAPELLA, G. (1996). Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res. 56, 5713-5719.
28. RICHARD, J.P., MELIKOV, K., VIVES, E., RAMOS, C., VERBEURE, B., GAIT, M.J., CHERNOMORDIK, L.V., and LEBLEU, B. (2003). Cell-penetrating peptides: A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
29. RIERA, M., CHILLON, M., ARAN, J.M., CRUZADO, J.M., TORRAS, J., GRINYO, J.M., and FILLAT, C. (2004). Intramuscular SP1017-formulated DNA electrotransfer enhances transgene expression and distributes hHGF to different rat tissues. J. Gene Med. 6, 111-118.
30. ROSENFELD, M.E., VICKERS, S.M., RABEN, D., WANG, M., SAMPSON, L., FENG, M., JAFFEE, E., and CURIEL, D.T. (1997). Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene. Ann. Surg. 225, 609-618; discussion 618-620.
31. SERSA, G., CEMAZAR, M., and RUDOLF, Z. (2003). Electrochemotherapy: Advantages and drawbacks in treatment of cancer patients. Cancer Ther. 1, 133-142.
32. SLACK, A., BOVENZI, V., BIGEY, P., IVANOV, M.A., RAMCHANDANI, S., BHATTACHARYA, S., TENOEVER, B., LAMRIHI, B., SCHERMAN, D., and SZYF, M. (2002). Antisense MBD2 gene therapy inhibits tumorigenesis. J. Gene Med. 4, 381-389.
33. TASCIOTTI, E., ZOPPE, M., and GIACCA, M. (2003). Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat. Cancer Gene Ther. 10, 64-74.
34. TYAGI, M., RUSNATI, M., PRESTA, M., and GIACCA, M. (2001). Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261.
35. WADIA, J.S., STAN, R.V., and DOWDY, S.F. (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315.
36. WATTS, R.L., RAISER, C.D., STOVER, N.P., CORNFELDT, M.L., SCHWEIKERT, A.W., ALLEN, R.C., SUBRAMANIAN, T., DOUDET, D., HONEY, C.R., and BAKAY, R.A. (2003). Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: A potential new cell therapy for Parkinson's disease. J. Neural Transm. Suppl. 65, 215-227.
37. WENDER, P.A., MITCHELL, D.J., PATTABIRAMAN, K., PELKEY, E.T., STEINMAN, L., and ROTHBARD, J.B. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008.
38. WU, S.C., HUANG, G.Y., and LIU, J.H. (2002). Production of retrovirus and adenovirus vectors for gene therapy: A comparative study using microcarrier and stationary cell culture. Biotechnol. Prog. 18, 617-622.
39. XIA, H., MAO, Q., and DAVIDSON, B.L. (2001). The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors. Nat. Biotechnol. 19, 640-644.